TITLE:
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection

CONDITION:
HIV Infections

INTERVENTION:
Tipranavir

SUMMARY:

      To provide early access to tipranavir and evaluate the safety and tolerance of tipranavir
      combined with low dose of ritonavir in patients with progressive, HIV-1 disease who have
      failed or are intolerant to currently approved treatments for HIV infection, who are unable
      to participate in another tipranavir controlled clinical trial and have an urgent need for
      anti-HIV treatment.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 2 Years to N/A
Criteria:

        Inclusion criteria:

        Patients aho have a positive serology HIV antibody test confirmed by Western blot, p24
        antigen assay, HIV-1 RNA or HIV culture and are highly pre-treated and virus resistant to
        multiple protease inhibitors.
      
